These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 6019059

  • 1. [On some essential differences of scleroderma, dermatomyositis and acute lupus erythematosus and the variegated therapy based on them].
    Korting GW.
    Dtsch Med Wochenschr; 1967 Feb 17; 92(7):281-8. PubMed ID: 6019059
    [No Abstract] [Full Text] [Related]

  • 2. Diagnostic criteria of dermatomyositis.
    Jablońska S.
    Pol Med J; 1966 Feb 17; 5(6):1472-83. PubMed ID: 5973047
    [No Abstract] [Full Text] [Related]

  • 3. [Comparative studies of the diagnostic usefulness of the intracutaneous leukocyte test and antinuclear factors in chronic lupus erythematosus].
    Sönnichsen N.
    Z Haut Geschlechtskr; 1967 Jun 15; 42(12):413-6. PubMed ID: 4872830
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Significance of immunofluorescence in dermatology].
    Holubar K.
    Z Haut Geschlechtskr; 1970 Feb 01; 45(3):113-20. PubMed ID: 4911829
    [No Abstract] [Full Text] [Related]

  • 7. [Diagnosis of most frequent autoimmune diseases].
    Kansky A.
    Med Arh; 1975 Feb 01; 29(2):93-6. PubMed ID: 1048999
    [No Abstract] [Full Text] [Related]

  • 8. [Letter: Suitability of immunofluorescence technics for the diagnosis of bullous eruptions, lupus erythematosus, and certain other dermatoses].
    Holubar K, Stingl G.
    Hautarzt; 1976 Jan 01; 27(1):30-9. PubMed ID: 767302
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical cutaneous lesions in the collagen diseases.
    Brodkin RH.
    J Med Soc N J; 1969 Nov 01; 66(11):625-8. PubMed ID: 4390716
    [No Abstract] [Full Text] [Related]

  • 14. [Use of antimetabolites in diseases of auto-aggression].
    Romiti N.
    Hospital (Rio J); 1968 Jan 01; 73(1):71-8. PubMed ID: 5308511
    [No Abstract] [Full Text] [Related]

  • 15. [Cross syndromes between systemic scleroderma and other connective tissue diseases].
    Guseva NG, Akhnazarova VD.
    Ter Arkh; 1974 Jan 01; 46(11):70-8. PubMed ID: 4439290
    [No Abstract] [Full Text] [Related]

  • 16. [M scleroderma (with systemic progressive sclerosis) associated with clinical and biological signs of dermatomyositis and lupus erythematosus].
    Grupper C, Durepaire RM, Eisenmann D, Briche R.
    Bull Soc Fr Dermatol Syphiligr; 1972 Jan 01; 79(3):219-20. PubMed ID: 4642837
    [No Abstract] [Full Text] [Related]

  • 17. Collagen vascular diseases.
    Callen JP.
    J Am Acad Dermatol; 2004 Sep 01; 51(3):427-39. PubMed ID: 15337987
    [No Abstract] [Full Text] [Related]

  • 18. [Determination of the antinuclear factors in lupus erythematosus].
    Sönnichsen N, Apostoloff G.
    Dermatol Wochenschr; 1965 Jul 24; 151(30):880-3. PubMed ID: 5844784
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.